New Funding Opportunities Available for Collaborative Rare Diseases Research

14 Sep New Funding Opportunities Available for Collaborative Rare Diseases Research

NCATS announced two new Rare Diseases Clinical Research Network (RDCRN) program funding opportunities to support collaborative clinical research on rare diseases. The Center is accepting applications for Rare Diseases Clinical Research Consortia and a Data Management and Coordinating Center (DMCC); both funding opportunities have a deadline of October 9, 2018.

The RDCRN is intended to advance the diagnosis, management and treatment of rare diseases with a focus on clinical trial readiness. Each consortium will promote highly collaborative, multi-site, patient-centric, translational and clinical research with the intent of addressing unmet clinical trial readiness needs.

The DMCC manages the collection, storage and quality control of clinical research data for the network. The RDCRN will emphasize data standards, which will facilitate data sharing among its members and others outside the network also studying rare diseases. NCATS will provide “cloud” computing services through the DMCC, enabling greater data accessibility and use. The DMCC will provide expertise and consulting to research consortia in several areas, such as the development and management of research study protocols, biostatistics, and study design. Learn more.